Medplus Health Services Ltd. · NSE:MEDPLUS
Medplus Health Services — Q2 FY2027 Earnings Presentation
27 slides from Medplus Health Services's earnings presentation, Oct 27, 2026
Slide 1: Cover letter to stock exchanges on earnings call presentation
MedPlus Health Services Limited October 27, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001 Bandra (East), Mumbai – 400 051 BSE Scrip Code: 54342
Slide 2: MedPlus Health Services Limited Q2 FY2027 Investor Presentation
MEDPLUS HEALTH SERVICES LIMITED Q2 FY2027 INVESTOR PRESENTATION October 2026
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by MedPlus Health Services Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: The MedPlus Story
The MedPlus Story Overview Marked presence of 20 years with network of 5,640+ Stores Spread across 13 states and 1 union territory Cluster based expansion strategy: ‘Continue 2nd Largest Pharma Retailer in the country deeper penetration vs. with pioneer in omni channel Wider reach’ Well curated SKU’
Slide 5: Q2 FY2027 Highlights (1/2)
Results Update Q2 FY2027 Highlights (1/2) ₹ 20,371m Revenue ₹ 5,108m Gross Margin • ₹ 3,578m increase over Q2FY26 • 25.1% GM%, lower by 110 bps yoy, 21.3% yoy increase by 60 bps qoq • ₹ 1,575m increase over Q1FY27 8.4% qoq • 0.6% decrease in private label over Q2FY26 166 Store Net Additions Stores >
Slide 6: Q2 FY2027 Highlights (2/2)
Results Update Q2 FY2027 Highlights (2/2) Revenue, ₹m Gross Margin Operating EBITDA EBITDA, ₹m 20,371 5.8% 26.1% 26.2% 26.5% 1,898 1,906 5.3% 5.4% 18,796 4.8% 1,769 Consolidated 18,644 25.1% 18,061 24.5% 1,663 1,531 16,793 3.5% 1,076 968 981 887 651 19,935 1,803 1,774 5.6% 1,688 25.3% 1,616 25.0% 25
Slide 7: H1 FY2027 Highlights
Results Update H1 FY2027 Highlights ₹ 39,167m Revenue ₹ 9,712m Gross Margin • ₹ 6,947m increase over H1FY26 • 24.8% GM%, decreased by 130 bps 21.6% yoy yoy • 0.7% decrease in private label over H1FY26 312 Store Net Additions Stores > 12 months • 441 gross additions • 14.9% revenue growth over H1FY26
Slide 8: Cluster Based Network Enables Profitable Omni-Channel Service
Cluster Based Network Enables Profitable Omni-Channel Service Overview Stores As On Sep-26 Strong Cluster Based Network Strong network of 5,642 stores across Metros, Tier-One, Tier-Two and beyond. 5,642 stores 2- hour delivery Ability to service 100% market – acute + chronic Online only players cann
Slide 9: Scale Allows A Large Private Label Basket: 1750+ SKUs
Scale Allows A Large Private Label Basket: 1750+ SKUs Overview Pharma Over 900 products covering Chronic, Acute, OTC & Other Pharmaceutical products Non-Pharma Over 850 products covering, packaged food, baked goods, dry goods, cleaning products, cosmetics and toiletries Q2FY27 7
Slide 10: Poised for Growth
Poised for Growth Overview Key Pillars Of Growth MedPlus has an established base of operations in 13 states and 1 union territory. Therefore, we will: Growth in existing clusters and • Further grow in cities where we have market leadership. Metro and Tier - One followed A develop new clusters by Tie
Slide 11: Stores Added In Last 12 Months
Results Update 712 Stores Added In Last 12 Months As On Sep-25 As On Mar-26 As On Sep-26 Presence 4,930 5,330 5,642 We are present in stores stores stores 13 states and 1 union territory. 1 1 1 The key urban 1 1 1 centers are: Bangalore, 33 691 43 753 57 764 Chennai, 47 45 63 Hyderabad, 587 179 610
Slide 12: Stores Added In Last Quarter
Results Update 166 Stores Added In Last Quarter Q2 FY27 Openings Q2 FY27 Closures Q2 FY27 Closure Reasons We opened 219 5.2 8.3 219 53 stores in Q2FY27 stores stores There were 53 14 16 closures 8 2 9 8 1 5 3 23 1.2 27 41 18 51 8 28 6 Relocation Franchisee withdrawn 32 14 6 1 Others Powered by Bing
Slide 13: Store Network: Age Structure
Results Update Store Network: 29% Less Than 2 Years Old Pharmacy: Count Pharmacy: Age Structure of Stores1 Stores 4.930 5,112 5,330 5,476 5,642 11% 14% 17% 19% 21% Openings 6,000 166 146 11% 218 9% Maintaining 182 7% 8% 117 8% steady store 5,000 openings 4,000 3,000 5,330 5,476 78% 4,930 5,112 77% 7
Slide 14: Profitable Older Stores: 12+ Months
Results Update Profitable Older Stores: 12+ Months Store Level Revenue Growth1 Store Level EBITDA Margin Store Level Operating ROCE2,3 17.8% 13.1% 77.7% 80.0% 12.4% 72.0% 15.3% 11.8% 11.7% 68.6% 13.2% 10.4% 62.6% 10.5% 2.2% Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q2FY27 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q2FY27 Q2FY26
Slide 15: Revenue Mix: Share of Private Label
Results Update Revenue Mix: Share of Private Label Revenue Mix: By Product Category Revenue Mix3: By Location of Stores 2.9% 2.7% 2.5% 2.9% 2.9% 9.8% 10.9% 11.0% 9.8% 10.7% 14% 14% 15% 15% 15% 12.2% 11.9% 11.6% 11.0% 10.7% 24% 24% 24% 24% 24% 9.2% 9.6% 9.5% 9.4% 9.2% 15% 16% 16% 16% 16% 65.9% 64.9%
Slide 16: Omni-channel: Profitable With Negligible Acquisition Costs
Results Update Omni-channel: Profitable With Negligible Acquisition Costs Channel Revenue Channel Delivery Pincodes1 and Delivery Hubs 1,200 8.0% 100% Hubs 690 699 711 727 735 1,112 Home Delivery Omni-Channel 1,100 7.0% 3,441 1,037 Our online 80% 3,223 3,043 3,021 3,077 presence grows 1,000 6.0% on
Slide 17: Income Statement
Results Update Income Statement Snapshot of Income Statement, ₹m Q2FY27 vs. 6m FY27 vs. Q2FY27 vs. Q2FY26 Q1FY27 Q2FY27 Q2FY26 6m FY26 6m FY27 6m FY26 Q1FY27(qoq) (yoy) (yoy) Revenue 16,793.3 18,796.0 20,371.1 21.3% 8.4% 32,219.6 39,167.1 21.6% Gross Margin 4,390.8 4,603.1 5,108.5 16.3% 11.0% 8,419.
Slide 18: Income Statement: Business Segments
Results Update Income Statement: Business Segments Snapshot of Income Statement, ₹m Q1FY27 Q2FY27 Pharmacy Pharmacy Diagnostic Others Total Diagnostic Others Total Retail Retail Revenue 18,398.7 370.8 26.5 18,796.0 19,935.4 410.5 25.2 20,371.1 COGS and Expenses 17,810.6 304.8 29.4 18,144.8 19,050.0
Slide 19: Income Statement: Ind AS Adjustments
Results Update Income Statement: Ind AS Adjustments Snapshot of Income Statement: Ind AS Adjustments, ₹m Q1FY27 Q2FY27 Ind AS Ind AS Ind AS Ind AS Reported Reported Impact Adjusted Impact Adjusted Revenue 18,796.0 - 18,796.0 20,371.1 - 20,371.1 Gross Margin 4,603.1 - 4,603.1 5,108.5 - 5,108.5 Gross
Slide 20: Operating EBITDA Deep Dive
Results Update Operating EBITDA Deep Dive Operating EBITDA Bridge: From 12+ Months Stores to Consolidated, ₹m 98 981 945 14 -2 885 -73 Operating 12+ Months < 12 Months Pre-Operative Pharmacy Diagnostics Others Consolidated EBITDA Stores Stores* * Includes all Franchisee stores Q2FY27 18
Slide 21: Balance Sheet
Results Update Balance Sheet Key Balance Sheet items, ₹m Sep-25 Mar-26 Jun-26 Sep-26 Assets PPE and CWIP 3,078.5 3,503.4 3,602.6 3,818.6 Inventories 12,807.4 13,816.9 14,395.6 15,210.9 Cash 6,085.0 5,942.1 6,218.8 4,621.5 Investments - - - 817.8 Liabilities Trade payables 3,393.4 3,069.5 3,595.5 3,6
Slide 22: Capital Productivity
Results Update Capital Productivity Working Capital Cycle, days ROCE2: Operating EBIT/ Avg. Capital Employed NWC (days) 53 53 53 54 54 26.3% 37 24.2% 37 35 36 35 22.5% Year 1 Stores 20.7% 34 86 days inventory 33 34 33 (on Year 1 stores 30 revenue) 12.6% Stores Older 19 Than 12 months 17 17 16 15 34
Slide 23: Cash Management
Results Update Cash Management Cash Management, Q2FY27, ₹m 4,000 Operating Cash Flow 3,000 ₹ 370m Free Cash Flow ₹ -840m 2,000 1,864 1,000 -1,256 -238 0 -436 55 -1,000 -775 -785 -2,000 PBT+ Increase in Taxes Capex Payment Interest Increase D&A+ Int. Working of lease received in cash of Lease Capital
Slide 24: Appendix
Appendix A. The Board of Directors and Key Managerial Personnel B. Glossary 22
Slide 25: The Board of Directors and Management Team
A. The Board of Directors and Management Team Appendix Mr. Gangadi Madhukar Reddy Dr. Cherukupalli Bhaskar Reddy Mr. Ajit Pandurang Rangnekar Ms. Aparna Surabhi Mr. Mohan Krishna Reddy Arvabumi Chairman, Managing Director Whole Time Director Non-Executive Non-Executive Non-Executive and Chief Execut
Slide 26: Glossary
B. Glossary Appendix Term Description Metro: Bengaluru, Chennai (and Avadi), Hyderabad, Kolkata (and Howrah), Mumbai (and Thane) City Categorization Tier One: Ahmednagar, Baramati, Kharagpur, Nagpur, Nashik, Panruti, Pune, Ranaghat, Vijayawada, Visakhapatnam (internal) Tier Two: Hundred and Thirty f
Slide 27: MedPlus Health Services Limited Contact
MEDPLUS HEALTH SERVICES LIMITED Website: www.medplusindia.com INVESTOR RELATIONS Tanushree Chaurasia [email protected] MEDIA AND PRESS ENQUIRIES [email protected] Reg. Office: H. No: 11-6-56, Survey No: 257 & 258/1 Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad, Telangana,
MedPlus Health Services — Q2 FY2027 Earnings Presentation on 6ix